特发性肺纤维化中医诊疗指南  

Guidelines for diagnosis and treatment of Chinese medicine on idiopathic pulmonary fibrosis

作　　者：世界中医药学会联合会内科专业委员会 李建生[2] 余学庆 Internal Medicine Committee of World Federation of Chinese Medicine Societies

机构地区：[1]不详 [2]河南中医药大学 [3]河南中医药大学第一附属医院

出　　处：《中国循证医学杂志》2025年第3期249-255,共7页Chinese Journal of Evidence-based Medicine

基　　金：国家中医药管理局中医药传承与创新“百千万”人才工程—岐黄工程首席科学家项目(编号:国中医药人教函[2020]219号);国家中医药管理局国家中医药传承创新团队项目(编号:ZYYCXTD-C-202206);国家自然科学基金项目(编号:U23A20503)。

摘　　要：特发性肺纤维化(IPF)是一种病因不明、进行性纤维化型间质性肺疾病,严重危害公众健康。中医诊疗IPF存在一定优势并在临床中广泛应用,为促进中医诊疗IPF水平的提高,世界中医药学会联合会内科专业委员会组织成立了具有多学科背景的指南制订小组,依据临床实践指南制订规范,基于现有最佳证据,权衡干预措施的利弊,综合考虑临床医师和患者意见,最终形成了IPF中医诊疗指南,供各级医疗机构的呼吸内科(中医、中西医结合、西医)医师临床诊疗及开展科研工作时参考使用。Idiopathic pulmonary fibrosis(IPF)is a chronic fibrotic and interstitial lung disease of unknown cause.It has a serious impact on people's health.Traditional Chinese medicine(TCM)has certain advantages in diagnosing and treating on IPF,which have been widely used in clinic.In order to improve the diagnostic and treatment level for IPF with TCM.The Internal Medicine Committee of World Federation of Chinese Medicine Societies organized and established a multidisciplinary background working group.The document was formulated by referring to the formulation method and process of clinical practice guidelines,which are based on the best evidence and the opinions of clinical physicians and patients.Physicians can use this guideline to make clinical decisions.

关 键 词：特发性肺纤维化 中医 临床实践指南 

分 类 号：R56[医药卫生—呼吸系统]